纳特拉基因检测

US · NTRA #387 按市值排名上市于 2015

393.44 -11.35 -2.80%

实时 - 追踪5344个代码 - 心跳于526秒前 · 2026-10-16 19:59

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了3家。
机构持股总比例下降了0.8个百分点。

机构持股

机构持股比例: 97.11% -0.78pp
机构数量: 1,022 -3
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund70.63%

Hedge Fund13.81%

Public Company4.45%

Individual/Insider2.75%

Family Office/Trust2.33%

VC/PE Fund1.51%

Private Company1.40%

Government Pension Fund1.40%

Sovereign Wealth Fund1.33%

Other0.40%

主要股东截至 2026-06-30

BlackRock 7.57% · 10.91M 股

J.P. Morgan Asset Management, Inc. 7.24% · 10.43M 股

T. Rowe Price Group, Inc. 7.04% · 10.15M 股

Vanguard Capital Management, LLC 4.96% · 7.15M 股

Vanguard Portfolio Management, LLC 4.01% · 5.78M 股

FMR 3.74% · 5.39M 股

Wellington Management Group 2.80% · 4.04M 股

State Street Global Advisors 2.54% · 3.66M 股

Duquesne Family Office LLC 2.21% · 3.19M 股

Geode Capital Management, LLC 1.91% · 2.75M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 13次买入 · 37次卖出

姓名	职务	持股比例
Matthew Rabinowitz	Co-Founder & Executive Chairperson	1.42%
Roelof Botha	Lead Independent Director	0.75%
Jonathan Sheena	Co-Founder	0.16%
John Fesko	President & Chief Business Officer	0.11%
Daniel Rabinowitz	Secretary & Chief Legal Officer	0.10%
Solomon Moshkevich	President of Clinical Diagnostics	0.07%
Steven Chapman	Chief Executive Officer	0.07%
James Healy	Independent Director	0.03%
Roy Baynes	Independent Director	0.01%
Michael Brophy	Chief Financial Officer	0.01%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-30	Solomon Moshkevich	President of Clinical Diagnostics	Automatic Disposition	-3,000	$411.62–415.07
2026-09-30	Steven Chapman	Chief Executive Officer	Automatic Disposition	-1,273	$413.31
2026-09-22	Jonathan Sheena	Co-Founder	Automatic Disposition	-18,064	$385.10–390.53
2026-09-15	Jonathan Sheena	Co-Founder	Automatic Disposition	-9,150	$348.03–356.87
2026-09-15	Solomon Moshkevich	President of Clinical Diagnostics	Other Disposition	-945	--
2026-09-14	Matthew Rabinowitz	Co-Founder & Executive Chairperson	Automatic Disposition	-102,000	$328.09–351.25
2026-09-10	Matthew Rabinowitz	Co-Founder & Executive Chairperson	Automatic Disposition	-50,000	$325.01–329.62
2026-09-01	Solomon Moshkevich	President of Clinical Diagnostics	Automatic Disposition	-18,160	$319.76–326.89
2026-08-31	Solomon Moshkevich	President of Clinical Diagnostics	Intent to Sell (Form 144)	-3,000	$320.73
2026-08-31	Steven Chapman	Chief Executive Officer	Automatic Disposition	-1,698	$320.99
2026-08-09	Jonathan Sheena	Co-Founder	Automatic Disposition	-6,000	$325.32
2026-08-09	John Fesko	President & Chief Business Officer	Automatic Disposition	-6,517	$321.53
2026-08-06	Matthew Rabinowitz	Co-Founder & Executive Chairperson	Automatic Disposition	-2,000	$320.90
2026-08-06	Jonathan Sheena	Co-Founder	Automatic Disposition	-9,150	$308.40–320.90
2026-08-05	John Fesko	President & Chief Business Officer	Other Acquisition	+20,000	--
2026-08-03	Michael Brophy	Chief Financial Officer	Automatic Disposition	-795	$267.99–274.22
2026-08-03	Michael Brophy	Chief Financial Officer	Intent to Sell (Form 144)	-478	$270.36
2026-08-02	Matthew Rabinowitz	Co-Founder & Executive Chairperson	Automatic Disposition	-731	$267.99
2026-08-02	Jonathan Sheena	Co-Founder	Automatic Disposition	-109	$267.99
2026-08-02	Solomon Moshkevich	President of Clinical Diagnostics	Automatic Disposition	-3,410	$259.98–268.70

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:59:50 · 仅供参考，不构成投资建议，也未考虑您的具体情况。